| Sarah L Roberts, MD | |
|
4300 Bartlett St, Homer, AK 99603-7005 | |
| (907) 235-8586 | |
| Not Available |
| Full Name | Sarah L Roberts |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 16 Years |
| Location | 4300 Bartlett St, Homer, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417117086 | NPI | - | NPPES |
| MD0316 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QA0505X | Family Medicine - Adult Medicine | 7166 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Peninsula Hospital | Homer, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Peninsula Hospital Inc | 5395636930 | 43 |
News Archive
At Masses across the country Sunday, Roman Catholic priests blasted the Obama administration's compromise on contraceptive insurance coverage, a sign the White House's backtrack late last week did little to defuse the controversy. The new policy requires religious employers such as universities and charities to cover contraception in employee health plans but shifts the responsibility for paying for it away from the employer and on to its health-insurance provider. Previously, the administration had required all employers apart from churches to cover contraception in their employee-insurance plans.
The U.N. Development Programme (UNDP) recently launched the Global Water Solidarity Platform "at the World Water Forum in Marseille, France, where 20,000 participants from the private, public and non-profit sectors [met] to address the water crisis," according to a UNDP press release.
Results from a new study show that risk factors for cardiovascular disease and diabetes were similar when participants consumed a healthy US-style eating pattern with and without an additional 5.3 ounces of lean beef.
Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the first quarter ended April 2, 2011.
NovaBay(R) Pharmaceuticals, Inc. (NYSE-Amex: NBY), (http://www.novabaypharma.com), a clinical stage company developing novel anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, announced today the start of a Phase 2a proof-of-concept study of its lead Aganocide(R) compound NVC-422 in impetigo.
› Verified 8 days ago
| Entity Name | South Peninsula Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679566269 PECOS PAC ID: 5395636930 Enrollment ID: O20040323000583 |
News Archive
At Masses across the country Sunday, Roman Catholic priests blasted the Obama administration's compromise on contraceptive insurance coverage, a sign the White House's backtrack late last week did little to defuse the controversy. The new policy requires religious employers such as universities and charities to cover contraception in employee health plans but shifts the responsibility for paying for it away from the employer and on to its health-insurance provider. Previously, the administration had required all employers apart from churches to cover contraception in their employee-insurance plans.
The U.N. Development Programme (UNDP) recently launched the Global Water Solidarity Platform "at the World Water Forum in Marseille, France, where 20,000 participants from the private, public and non-profit sectors [met] to address the water crisis," according to a UNDP press release.
Results from a new study show that risk factors for cardiovascular disease and diabetes were similar when participants consumed a healthy US-style eating pattern with and without an additional 5.3 ounces of lean beef.
Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the first quarter ended April 2, 2011.
NovaBay(R) Pharmaceuticals, Inc. (NYSE-Amex: NBY), (http://www.novabaypharma.com), a clinical stage company developing novel anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, announced today the start of a Phase 2a proof-of-concept study of its lead Aganocide(R) compound NVC-422 in impetigo.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah L Roberts, MD 4300 Bartlett St, Homer, AK 99603-7005 Ph: (907) 235-8586 | Sarah L Roberts, MD 4300 Bartlett St, Homer, AK 99603-7005 Ph: (907) 235-8586 |
News Archive
At Masses across the country Sunday, Roman Catholic priests blasted the Obama administration's compromise on contraceptive insurance coverage, a sign the White House's backtrack late last week did little to defuse the controversy. The new policy requires religious employers such as universities and charities to cover contraception in employee health plans but shifts the responsibility for paying for it away from the employer and on to its health-insurance provider. Previously, the administration had required all employers apart from churches to cover contraception in their employee-insurance plans.
The U.N. Development Programme (UNDP) recently launched the Global Water Solidarity Platform "at the World Water Forum in Marseille, France, where 20,000 participants from the private, public and non-profit sectors [met] to address the water crisis," according to a UNDP press release.
Results from a new study show that risk factors for cardiovascular disease and diabetes were similar when participants consumed a healthy US-style eating pattern with and without an additional 5.3 ounces of lean beef.
Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the first quarter ended April 2, 2011.
NovaBay(R) Pharmaceuticals, Inc. (NYSE-Amex: NBY), (http://www.novabaypharma.com), a clinical stage company developing novel anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, announced today the start of a Phase 2a proof-of-concept study of its lead Aganocide(R) compound NVC-422 in impetigo.
› Verified 8 days ago
Paul Leo Eneboe, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4136 Bartlett St, Homer Medical Clinic, Homer, AK 99603 Phone: 907-235-8586 Fax: 907-235-6639 | |
Randall Habecker Wiest, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4136 Bartlett St, Homer Medical Clinic, Homer, AK 99603 Phone: 907-235-8586 Fax: 907-235-6639 | |
Prof. Clarence O. Hughes, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1850 Jade Dr., Homer, AK 99603 Phone: 907-235-4229 Fax: 907-235-1936 | |
David Robert Downey, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 203 W Pioneer Ave Ste 3, Homer, AK 99603 Phone: 907-435-3070 Fax: 907-435-3079 | |
Tim W Scheffel, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 3179 Lake St, Homer, AK 99603 Phone: 907-299-6069 Fax: 888-639-5730 | |
Giulia Marie Tortora, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4136 Bartlett St, Homer Medical Clinic, Homer, AK 99603 Phone: 907-235-8586 Fax: 907-235-6639 |